메뉴 건너뛰기




Volumn 9, Issue 9, 2013, Pages 557-563

Advances from clinical trials in juvenile idiopathic arthritis

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; AURANOFIN; CALGRANULIN A; CALGRANULIN B; CANAKINUMAB; CERTOLIZUMAB PEGOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; PENICILLAMINE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; TOCILIZUMAB; TOLMETIN;

EID: 84883462499     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.105     Document Type: Review
Times cited : (40)

References (56)
  • 1
    • 84863552263 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis
    • Espinosa, M. & Gottlieb, B. S. Juvenile idiopathic arthritis. Pediatr. Rev. 33, 303-313 (2012).
    • (2012) Pediatr. Rev. , vol.33 , pp. 303-313
    • Espinosa, M.1    Gottlieb, B.S.2
  • 2
    • 0017695324 scopus 로고
    • Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis
    • Levinson, J. E. et al. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. J. Pediatr. 91, 799-804 (1977).
    • (1977) J. Pediatr. , vol.91 , pp. 799-804
    • Levinson, J.E.1
  • 3
    • 0028800309 scopus 로고
    • Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future
    • Giannini, E. H. & Cawkwell, G. D. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. Pediatr. Clin. North Am. 42, 1099-1125 (1995).
    • (1995) Pediatr. Clin. North Am. , vol.42 , pp. 1099-1125
    • Giannini, E.H.1    Cawkwell, G.D.2
  • 4
    • 0019985236 scopus 로고
    • Standard methodology for segment i II, and III pediatric rheumatology collaborative study group studies. I. Design
    • Brewer, E. J. & Giannini, E. H. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. I. Design. J. Rheumatol. 9, 109-113 (1982).
    • (1982) J. Rheumatol. , vol.9 , pp. 109-113
    • Brewer, E.J.1    Giannini, E.H.2
  • 5
    • 0020328331 scopus 로고
    • Standard methodology for segment i II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data
    • Giannini, E. H. & Brewer, E. J. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data. J. Rheumatol. 9, 114-122 (1982).
    • (1982) J. Rheumatol. , vol.9 , pp. 114-122
    • Giannini, E.H.1    Brewer, E.J.2
  • 6
    • 0021328911 scopus 로고
    • Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis
    • Bunch, T. W. et al. Controlled trial of hydroxychloroquine and d-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum. 27, 267-276 (1984).
    • (1984) Arthritis Rheum , vol.27 , pp. 267-276
    • Bunch, T.W.1
  • 7
    • 0022573025 scopus 로고
    • Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial
    • Brewer, E. J., Giannini, E. H., Kuzmina, N. & Alekseev, L. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N. Engl. J. Med. 314, 1269-1276 (1986).
    • (1986) N. Engl. J. Med. , vol.314 , pp. 1269-1276
    • Brewer, E.J.1    Giannini, E.H.2    Kuzmina, N.3    Alekseev, L.4
  • 8
    • 0025317654 scopus 로고
    • Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled cooperative trial
    • The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group
    • Giannini, E. H., Brewer, E. J., Kuzmina, N., Shaikov, A. & Wallin, B. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled cooperative trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. Arthritis Rheum. 33, 466-476 (1990).
    • (1990) Arthritis Rheum. , vol.33 , pp. 466-476
    • Giannini, E.H.1    Brewer, E.J.2    Kuzmina, N.3    Shaikov, A.4    Wallin, B.5
  • 9
    • 0026579862 scopus 로고
    • Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial
    • Williams, H. J. et al. Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum. 35, 1406-1407 (1992).
    • (1992) Arthritis Rheum , vol.35 , pp. 1406-1407
    • Williams, H.J.1
  • 10
    • 0026609159 scopus 로고
    • Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial
    • The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
    • Giannini, E. H. et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N. Engl. J. Med. 326, 1043-1049 (1992).
    • (1992) N. Engl. J. Med. , vol.326 , pp. 1043-1049
    • Giannini, E.H.1
  • 11
    • 3142746016 scopus 로고    scopus 로고
    • A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
    • Ruperto, N. et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 50, 2191-2201 (2004).
    • (2004) Arthritis Rheum. , vol.50 , pp. 2191-2201
    • Ruperto, N.1
  • 12
    • 0030960980 scopus 로고    scopus 로고
    • Preliminary definition of improvement in juvenile arthritis
    • Giannini, E. H. et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 40, 1202-1209 (1997).
    • (1997) Arthritis Rheum , vol.40 , pp. 1202-1209
    • Giannini, E.H.1
  • 13
    • 80051741699 scopus 로고    scopus 로고
    • American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
    • Wallace, C. A. et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 63, 929-936 (2011).
    • (2011) Arthritis Care Res. (Hoboken) , vol.63 , pp. 929-936
    • Wallace, C.A.1
  • 14
    • 0029982473 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: A phase I/II study
    • Pediatric Rheumatology Collaborative Study Group
    • Giannini, E. H. et al. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. J. Rheumatol. 23, 919-924 (1996).
    • (1996) J. Rheumatol. , vol.23 , pp. 919-924
    • Giannini, E.H.1
  • 15
    • 0034673697 scopus 로고    scopus 로고
    • Etanercept in children with polyarticular juvenile rheumatoid arthritis
    • Pediatric Rheumatology Collaborative Study Group
    • Lovell, D. J. et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N. Engl. J. Med. 342, 763-769 (2000).
    • (2000) N. Engl. J. Med. , vol.342 , pp. 763-769
    • Lovell, D.J.1
  • 16
    • 84861815507 scopus 로고    scopus 로고
    • Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis
    • Wallace, C. A. et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 64, 2012-2021 (2012).
    • (2012) Arthritis Rheum , vol.64 , pp. 2012-2021
    • Wallace, C.A.1
  • 17
    • 0032888041 scopus 로고    scopus 로고
    • A look at the future of pediatric therapeutics: An investigator's perspective of the new pediatric rule
    • Connor, J. D. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule. Pediatrics 104, 610-613 (1999).
    • (1999) Pediatrics , vol.104 , pp. 610-613
    • Connor, J.D.1
  • 18
    • 85007680228 scopus 로고    scopus 로고
    • Use of unlabeled and off license drugs in children. A European paediatric rule is needed to protect children
    • Ruperto, N. & Martini, A. Use of unlabeled and off license drugs in children. A European paediatric rule is needed to protect children. BMJ 320, 1210-1211 (2000).
    • (2000) BMJ , vol.320 , pp. 1210-1211
    • Ruperto, N.1    Martini, A.2
  • 19
    • 33947432434 scopus 로고    scopus 로고
    • Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004
    • European Parliament, Council
    • European Parliament, Council. Regulation (EC) no 1901/2006 of the European parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 378, 1-19 (2006).
    • (2006) Official Journal of the European Union , vol.378 , pp. 1-19
  • 20
    • 10744230484 scopus 로고    scopus 로고
    • International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001
    • Petty, R. E. et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J. Rheumatol. 31, 390-392 (2004).
    • (2004) J. Rheumatol. , vol.31 , pp. 390-392
    • Petty, R.E.1
  • 21
    • 34848884299 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
    • Ruperto, N. et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 56, 3096-3106 (2007).
    • (2007) Arthritis Rheum. , vol.56 , pp. 3096-3106
    • Ruperto, N.1
  • 22
    • 49949115223 scopus 로고    scopus 로고
    • Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
    • Lovell, D. J. et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N. Engl. J. Med. 359, 810-820 (2008).
    • (2008) N. Engl. J. Med. , vol.359 , pp. 810-820
    • Lovell, D.J.1
  • 23
    • 84883451142 scopus 로고    scopus 로고
    • US National Library Of Medicine. ClinicalTrials.gov
    • US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01230827 (2013).
    • (2013)
  • 24
    • 84883461426 scopus 로고    scopus 로고
    • US National Library Of Medicine. ClinicalTrials.gov
    • US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01550003 (2013).
    • (2013)
  • 25
    • 0029766227 scopus 로고    scopus 로고
    • Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy
    • Grom, A. A. et al. Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum. 39, 1703-1710 (1996).
    • (1996) Arthritis Rheum , vol.39 , pp. 1703-1710
    • Grom, A.A.1
  • 26
    • 9644255827 scopus 로고    scopus 로고
    • The German etanercept registry for treatment of juvenile idiopathic arthritis
    • Horneff, G. et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann. Rheum. Dis. 63, 1638-1644 (2004).
    • (2004) Ann. Rheum. Dis. , vol.63 , pp. 1638-1644
    • Horneff, G.1
  • 27
    • 66149142293 scopus 로고    scopus 로고
    • Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: The Dutch national register
    • Prince, F. H. et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann. Rheum. Dis. 68, 635-641 (2009).
    • (2009) Ann. Rheum. Dis. , vol.68 , pp. 635-641
    • Prince, F.H.1
  • 28
    • 78249250295 scopus 로고    scopus 로고
    • Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis
    • Giannini, E. H. et al. Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum. 62, 3259-3264 (2010).
    • (2010) Arthritis Rheum , vol.62 , pp. 3259-3264
    • Giannini, E.H.1
  • 29
    • 48349093002 scopus 로고    scopus 로고
    • Abatacept in children with juvenile idiopathic arthritis: A randomized, double-blind, placebo-controlled withdrawal trial
    • Ruperto, N. et al. Abatacept in children with juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled withdrawal trial. Lancet 372, 383-391 (2008).
    • (2008) Lancet , vol.372 , pp. 383-391
    • Ruperto, N.1
  • 30
    • 0034735842 scopus 로고    scopus 로고
    • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group
    • Lipsky, P. E. et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med. 343, 1594-1602 (2000).
    • (2000) N. Engl. J. Med. , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1
  • 31
    • 84883459745 scopus 로고    scopus 로고
    • European Medicines Agency, EPAR summary for the public: Humira
    • European Medicines Agency. EPAR summary for the public: Humira [online], http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Summary-for-the- public/human/000481/WC500050865.pdf (2013).
    • (2013)
  • 32
    • 79959370461 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis
    • .. Prakken, B., Albani, S. & Martini, A. Juvenile idiopathic arthritis. Lancet 377, 2138-2149 (2011).
    • (2011) Lancet , vol.377 , pp. 2138-2149
    • Prakken, B.1    Albani, S.2    Martini, A.3
  • 33
    • 0031993121 scopus 로고    scopus 로고
    • Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?
    • De Benedetti, F. & Martini, A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J. Rheumatol. 25, 203-207 (1998).
    • (1998) J. Rheumatol. , vol.25 , pp. 203-207
    • De Benedetti, F.1    Martini, A.2
  • 34
    • 18644385243 scopus 로고    scopus 로고
    • Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
    • Pascual, V., Allantaz, F., Arce, E., Punaro, M. & Banchereau, J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201, 1479-1486 (2005).
    • (2005) J. Exp. Med. , vol.201 , pp. 1479-1486
    • Pascual, V.1    Allantaz, F.2    Arce, E.3    Punaro, M.4    Banchereau, J.5
  • 35
    • 77956526510 scopus 로고    scopus 로고
    • Tocilizumab: Molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    • Yokota, S. & Kishimoto, T. Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis. Expert Rev. Clin. Immunol. 6, 735-743 (2010).
    • (2010) Expert Rev. Clin. Immunol. , vol.6 , pp. 735-743
    • Yokota, S.1    Kishimoto, T.2
  • 36
    • 84871318830 scopus 로고    scopus 로고
    • Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
    • De Benedetti, F. et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2385-2395 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 2385-2395
    • De Benedetti, F.1
  • 37
    • 79953323633 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
    • Quartier, P. et al. A multicenter, randomized, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann. Rheum. Dis. 70, 747-754 (2011).
    • (2011) Ann. Rheum. Dis. , vol.70 , pp. 747-754
    • Quartier, P.1
  • 38
    • 84856370186 scopus 로고    scopus 로고
    • A phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
    • Ruperto, N. et al. A phase II study to evaluate dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum. 64, 557-567 (2012).
    • (2012) Arthritis Rheum. , vol.64 , pp. 557-567
    • Ruperto, N.1
  • 39
    • 84871321221 scopus 로고    scopus 로고
    • Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
    • Ruperto, N. et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2396-2407 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 2396-2407
    • Ruperto, N.1
  • 40
    • 84871316266 scopus 로고    scopus 로고
    • A new era in the treatment of systemic juvenile idiopathic arthritis
    • Sandborg, C. & Mellins, E. D. A new era in the treatment of systemic juvenile idiopathic arthritis. N. Engl. J. Med. 367, 2439-2440 (2012).
    • (2012) N. Engl. J. Med. , vol.367 , pp. 2439-2440
    • Sandborg, C.1    Mellins, E.D.2
  • 41
    • 80051470174 scopus 로고    scopus 로고
    • Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): A multicenter randomized open-label clinical trial
    • Tynjala, P. et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicenter randomized open-label clinical trial. Ann. Rheum. Dis. 70, 1605-1612 (2011).
    • (2011) Ann. Rheum. Dis. , vol.70 , pp. 1605-1612
    • Tynjala, P.1
  • 42
    • 79957483535 scopus 로고    scopus 로고
    • 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
    • Beukelman, T. et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. (Hoboken) 63, 465-482 (2011).
    • (2011) Arthritis Care Res. (Hoboken) , vol.63 , pp. 465-482
    • Beukelman, T.1
  • 43
    • 84883460572 scopus 로고    scopus 로고
    • Predictive markers of therapeutical outcome and their role in the ethiopathology of juvenile idiopathic arthritis [abstract]
    • Rossetti, M. et al. Predictive markers of therapeutical outcome and their role in the ethiopathology of juvenile idiopathic arthritis [abstract]. Arthritis Rheum. 64 (Suppl. 10), S1097-S1098 (2012).
    • (2012) Arthritis Rheum. , vol.64 , Issue.SUPPL. 10
    • Rossetti, M.1
  • 44
    • 77950512831 scopus 로고    scopus 로고
    • Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
    • Foell, D. et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 303, 1266-1273 (2010).
    • (2010) JAMA , vol.303 , pp. 1266-1273
    • Foell, D.1
  • 45
    • 84868453277 scopus 로고    scopus 로고
    • Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: A comparative study
    • Gerss, J. et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann. Rheum. Dis. 71, 1991-1997 (2012).
    • (2012) Ann. Rheum. Dis. , vol.71 , pp. 1991-1997
    • Gerss, J.1
  • 46
    • 85005769188 scopus 로고    scopus 로고
    • Summary of AHRQ's comparative effectiveness review of disease-modifying antirheumatic drugs for children with juvenile idiopathic arthritis
    • McMahan, R., Balfe, L. M. & Greene, L. Summary of AHRQ's comparative effectiveness review of disease-modifying antirheumatic drugs for children with juvenile idiopathic arthritis. J. Manag. Care Pharm. 18 (Suppl. B), 1-16 (2012).
    • (2012) J. Manag. Care Pharm. , vol.18 , Issue.SUPPL. B , pp. 1-16
    • McMahan, R.1    Balfe, L.M.2    Greene, L.3
  • 47
    • 84863428204 scopus 로고    scopus 로고
    • Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis
    • DeWitt, E. M. et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 64, 1001-1010 (2012).
    • (2012) Arthritis Care Res. (Hoboken) , vol.64 , pp. 1001-1010
    • Dewitt, E.M.1
  • 48
    • 84857227050 scopus 로고    scopus 로고
    • A european network of paediatric research at the european medicines agency (Enpr-EMA)
    • Ruperto, N. et al. A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). Arch. Dis. Child. 97, 185-188 (2012).
    • (2012) Arch. Dis. Child. , vol.97 , pp. 185-188
    • Ruperto, N.1
  • 49
    • 52649108201 scopus 로고    scopus 로고
    • Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis
    • Nielsen, S. et al. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 26, 688-692 (2008).
    • (2008) Clin. Exp. Rheumatol. , vol.26 , pp. 688-692
    • Nielsen, S.1
  • 50
    • 77957584399 scopus 로고    scopus 로고
    • The safety profile of biologic therapies for juvenile idiopathic arthritis
    • Hashkes, P. J. Uziel, Y. & Laxer, R. M. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat. Rev. Rheumatol. 6, 561-571 (2010).
    • (2010) Nat. Rev. Rheumatol. , vol.6 , pp. 561-571
    • Hashkes, P.J.1    Uziel, Y.2    Laxer, R.M.3
  • 51
    • 77955371398 scopus 로고    scopus 로고
    • Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the Food and Drug Administration
    • Diak, P. et al. Tumor necrosis factor α blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum. 62, 2517-2524 (2010).
    • (2010) Arthritis Rheum , vol.62 , pp. 2517-2524
    • Diak, P.1
  • 52
    • 84866175338 scopus 로고    scopus 로고
    • Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
    • Beukelman, T. et al. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 64, 1263-1271 (2012).
    • (2012) Arthritis Rheum , vol.64 , pp. 1263-1271
    • Beukelman, T.1
  • 53
    • 78649648584 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study
    • Simard, J., Neovius, M., Hagelberg, S. & Askling, J. Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study. Arthritis Rheum. 62, 3776-3782 (2010).
    • (2010) Arthritis Rheum. , vol.62 , pp. 3776-3782
    • Simard, J.1    Neovius, M.2    Hagelberg, S.3    Askling, J.4
  • 54
    • 78650990577 scopus 로고    scopus 로고
    • Pediatric rheumatology: JIA, treatment and possible risk of malignancies
    • Ruperto, N. & Martini, A. Pediatric rheumatology: JIA, treatment and possible risk of malignancies. Nat. Rev. Rheumatol. 7, 6-7 (2011).
    • (2011) Nat. Rev. Rheumatol. , vol.7 , pp. 6-7
    • Ruperto, N.1    Martini, A.2
  • 55
  • 56
    • 79953317032 scopus 로고    scopus 로고
    • Malignancies in juvenile idiopathic arthritis: A preliminary report
    • Bernatsky, S. et al. Malignancies in juvenile idiopathic arthritis: a preliminary report. J. Rheumatol. 38, 760-763 (2011).
    • (2011) J. Rheumatol. , vol.38 , pp. 760-763
    • Bernatsky, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.